...
首页> 外文期刊>Cureus. >Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide
【24h】

Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide

机译:用静脉内奥雷德雷德治疗的Chyolous腹水和胸腔积液

获取原文

摘要

Chylous ascites (CA) is uncommon in cirrhosis. It often presents as diuretic-resistant ascites and is associated with increased mortality. Diagnosis is done by the detection of triglyceride-rich ascitic fluid. There are no published guidelines on the management of CA. We describe the case of a middle-aged female who presented with CA secondary to cirrhosis, and the challenges associated with her treatment and her management with the use of intravenous octreotide.
机译:Chylous腹水(CA)在肝硬化中罕见。它通常呈现为利尿剂腹水,并且与死亡率增加相关。通过检测富含甘油三酯的腹水流体来完成诊断。没有关于加利福尼亚州管理指导方针。我们描述了介绍肝硬化的CA的中年女性的案例,以及与使用静脉内奥雷德雷德的治疗和管理相关的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号